Skip to content
10-Q

Quarterly Report

SUPERNUS PHARMACEUTICALS, INC. SUPN

0001356576-25-000071

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 29, 2025 57.34M sh
Shares Diluted Q3 2025 · Sep 30, 2025 56.55M sh
Shares Diluted Q3 2025 · Sep 30, 2025 56.13M sh
Shares Diluted Q3 2025 · Sep 30, 2024 56.02M sh
Shares Diluted Q3 2025 · Sep 30, 2024 55.79M sh
Capex Q3 2025 · Sep 30, 2025 $911K
Capex Q3 2025 · Sep 30, 2024 $512K
Operating Cash Flow Q3 2025 · Sep 30, 2025 $27.47M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $127.55M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $151.37M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $69.33M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $31.67M
Stockholders Equity Q3 2025 · Sep 30, 2025 $1.05B
Stockholders Equity Q3 2025 · Jun 30, 2025 $1.06B
Stockholders Equity Q3 2025 · Mar 31, 2025 $1.03B
Stockholders Equity Q3 2025 · Dec 31, 2024 $1.04B
Stockholders Equity Q3 2025 · Sep 30, 2024 $1.01B
Stockholders Equity Q3 2025 · Jun 30, 2024 $957.45M
Stockholders Equity Q3 2025 · Mar 31, 2024 $929.17M
Stockholders Equity Q3 2025 · Dec 31, 2023 $921.52M
Current Liabilities Q3 2025 · Sep 30, 2025 $330.63M
Current Liabilities Q3 2025 · Dec 31, 2024 $292.4M
Total Liabilities Q3 2025 · Sep 30, 2025 $370.09M
Total Liabilities Q3 2025 · Dec 31, 2024 $332.34M
Current Assets Q3 2025 · Sep 30, 2025 $593.89M
Current Assets Q3 2025 · Dec 31, 2024 $686.07M
Total Assets Q3 2025 · Sep 30, 2025 $1.42B
Total Assets Q3 2025 · Dec 31, 2024 $1.37B
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.80
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.61
Eps Diluted Q3 2025 · Sep 30, 2024 $0.69
Eps Diluted Q3 2025 · Sep 30, 2024 $1.05
Eps Basic Q3 2025 · Sep 30, 2025 −$0.80
Eps Basic Q3 2025 · Sep 30, 2025 −$0.61
Eps Basic Q3 2025 · Sep 30, 2024 $0.70
Eps Basic Q3 2025 · Sep 30, 2024 $1.06
Sga Expense Q3 2025 · Sep 30, 2025 $179.68M
Sga Expense Q3 2025 · Sep 30, 2025 $363.17M
Sga Expense Q3 2025 · Sep 30, 2024 $69.75M
Sga Expense Q3 2025 · Sep 30, 2024 $242.17M
Rd Expense Q3 2025 · Sep 30, 2025 $29.37M
Rd Expense Q3 2025 · Sep 30, 2025 $78.41M
Rd Expense Q3 2025 · Sep 30, 2024 $29.04M
Rd Expense Q3 2025 · Sep 30, 2024 $80.15M
Net Income Q3 2025 · Sep 30, 2025 −$45.12M
Net Income Q3 2025 · Sep 30, 2025 −$34.45M
Net Income Q3 2025 · Jun 30, 2025 $22.5M
Net Income Q3 2025 · Mar 31, 2025 −$11.83M
Net Income Q3 2025 · Sep 30, 2024 $38.5M
Net Income Q3 2025 · Sep 30, 2024 $58.54M
Net Income Q3 2025 · Jun 30, 2024 $19.92M
Net Income Q3 2025 · Mar 31, 2024 $124K
Operating Income Q3 2025 · Sep 30, 2025 −$60.23M
Operating Income Q3 2025 · Sep 30, 2025 −$58.35M
Operating Income Q3 2025 · Sep 30, 2024 $40.85M
Operating Income Q3 2025 · Sep 30, 2024 $60.26M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $18.97M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $51.56M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $17.58M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $51.81M
Revenue Q3 2025 · Sep 30, 2025 $192.1M
Revenue Q3 2025 · Sep 30, 2025 $507.38M
Revenue Q3 2025 · Sep 30, 2024 $175.69M
Revenue Q3 2025 · Sep 30, 2024 $487.66M